ARMP · Armata Pharmaceuticals, Inc.
$4.56
-0.26 (-5.39%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. While management believes this plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within our control and cannot be assessed as being probable of occurring.”View the 10-Q filed Aug 12, 2026
Market Cap
$169.55M
Shares
37.18M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
789,245
-7.8% vs reported
Short Squeeze Score
55/100
Short interest 2.3% of shares — P54
Days to cover 5.0 — P68
Price vs VWAP -23.9% — P10
Short-volume trend +2.9% — P63
Short interest change +21.5% — P86
Worst FTD 0.03% of shares — P59
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 856,363 | 704,657 | +151,706 | 4.98 |
| 2026-07-15 | 704,657 | 441,157 | +263,500 | 4.55 |
| 2026-06-30 | 441,157 | 206,873 | +234,284 | 1.46 |
| 2026-06-15 | 206,873 | 209,363 | -2,490 | 3.86 |
| 2026-05-29 | 209,363 | 225,033 | -15,670 | 2.48 |
| 2026-05-15 | 225,033 | 230,017 | -4,984 | 2.91 |
| 2026-04-30 | 230,017 | 244,306 | -14,289 | 2.89 |
| 2026-04-15 | 244,306 | 297,898 | -53,592 | 4.44 |
| 2026-03-31 | 297,898 | 310,810 | -12,912 | 9.66 |
| 2026-03-13 | 310,810 | 298,102 | +12,708 | 9.37 |
| 2026-02-27 | 298,102 | 298,337 | -235 | 4.46 |
| 2026-02-13 | 298,337 | 274,891 | +23,446 | 6.65 |
| 2026-01-30 | 274,891 | 222,054 | +52,837 | 6.63 |
| 2026-01-15 | 222,054 | 144,352 | +77,702 | 2.94 |
| 2025-12-31 | 144,352 | 133,987 | +10,365 | 5.29 |
| 2025-12-15 | 133,987 | 131,252 | +2,735 | 2.28 |
| 2025-11-28 | 131,252 | 157,247 | -25,995 | 1.88 |
| 2025-11-14 | 157,247 | 30,828 | +126,419 | 1.19 |
| 2025-10-31 | 30,828 | 21,970 | +8,858 | 1.00 |
| 2025-10-15 | 21,970 | 23,958 | -1,988 | 2.09 |
| 2025-09-30 | 23,958 | 27,906 | -3,948 | 2.84 |
| 2025-09-15 | 27,906 | 36,748 | -8,842 | 1.88 |
| 2025-08-29 | 36,748 | 49,502 | -12,754 | 3.79 |
Showing 1–23 of 23 settlements
Key facts
CIK
921114
CUSIP
04216R102
13F (30d)
51 filings
51 filers
Visit website
Investor relations